NYSE:CVS - CVS Health Stock Price, Forecast & News

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health announced a quarterly dividend on Thursday, January 2nd. Shareholders of record on Thursday, January 23rd will be given a dividend of $0.50 per share on Monday, February 3rd. This represents a $2.00 dividend on an annualized basis and a yield of 2.78%. The ex-dividend date of this dividend is Wednesday, January 22nd. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) released its earnings results on Wednesday, November, 6th. The pharmacy operator reported $1.84 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.77 by $0.07. The pharmacy operator had revenue of $64.81 billion for the quarter, compared to the consensus estimate of $62.99 billion. CVS Health had a net margin of 1.83% and a return on equity of 15.45%. The company's quarterly revenue was up 36.5% compared to the same quarter last year. During the same period last year, the firm earned $1.73 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for CVS Health.

CVS Health issued an update on its FY19 earnings guidance on Wednesday, November, 6th. The company provided EPS guidance of $6.97-7.05 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.98.

24 equities research analysts have issued 12 month price objectives for CVS Health's stock. Their forecasts range from $61.00 to $97.00. On average, they expect CVS Health's stock price to reach $77.43 in the next twelve months. This suggests a possible upside of 7.6% from the stock's current price. View Analyst Price Targets for CVS Health.

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 6 hold ratings, 17 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

News coverage about CVS stock has been trending positive this week, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. CVS Health earned a news impact score of 3.0 on InfoTrie's scale. They also gave media coverage about the pharmacy operator a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for CVS Health.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Covetrus (CVET), Rite Aid (RAD), 111 (YI), Petmed Express (PETS), Diplomat Pharmacy (DPLO), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), Cisco Systems (CSCO), NVIDIA (NVDA), Alibaba Group (BABA), Home Depot (HD), Verizon Communications (VZ), Johnson & Johnson (JNJ), Intel (INTC) and QUALCOMM (QCOM).

CVS Health's stock is owned by a variety of of institutional and retail investors. Top institutional investors include California Public Employees Retirement System (0.24%), New York State Teachers Retirement System (0.15%), Hexavest Inc. (0.09%), SPF Beheer BV (0.09%), M&G Investment Management Ltd. (0.08%) and Focused Investors LLC (0.06%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, Helena Foulkes, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Troyen A Brennan and Vost Collin. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including State of Michigan Retirement System, Assenagon Asset Management S.A., Rhenman & Partners Asset Management AB, Coronation Fund Managers Ltd., Commerzbank Aktiengesellschaft FI, Strs Ohio, Meag Munich Ergo Kapitalanlagegesellschaft MBH and Janney Montgomery Scott LLC. Company insiders that have sold CVS Health company stock in the last year include Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Larry J Merlo and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was purchased by a variety of institutional investors in the last quarter, including M&G Investment Management Ltd., DNB Asset Management AS, Artemis Investment Management LLP, Johanson Financial Advisors Inc., Zurcher Kantonalbank Zurich Cantonalbank, California Public Employees Retirement System, Douglas Lane & Associates LLC and Corbenic Partners LLC. Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $71.93.

CVS Health has a market capitalization of $93.58 billion and generates $194.58 billion in revenue each year. The pharmacy operator earns $-594,000,000.00 in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 295,000 workers across the globe.View Additional Information About CVS Health.

The official website for CVS Health is http://www.cvshealth.com/.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]